S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Dollar General May Create an Opportunity for Patient Investors
Is Frontline's 20% Dividend Too Good To Be True?
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Reasons The Wayfair Rally Is Way Overdone
Wheat prices jump following collapse of major dam in southern Ukraine
Lithium Has Boomed And This American Stock Is Ready.. (Ad)
Here’s What’s Driving the Price of Carvana Higher
Stock market today: Wall Street inches higher toward edge of bull market
NASDAQ:BYSI

BeyondSpring (BYSI) Stock Forecast, Price & News

$1.25
-0.12 (-8.76%)
(As of 06/6/2023 ET)
Compare
Today's Range
$1.25
$1.40
50-Day Range
$0.89
$1.39
52-Week Range
$0.54
$3.45
Volume
59,277 shs
Average Volume
215,388 shs
Market Capitalization
$48.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.25

BYSI stock logo

About BeyondSpring (NASDAQ:BYSI) Stock

BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in New York, NY.

Receive BYSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.

BYSI Stock News Headlines

Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Lithium Has Boomed And This American Stock Is Ready..
Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!
BeyondSpring Files 2022 Annual Report on Form 20-F
Why Are BeyondSpring Shares Trading Higher?
BeyondSpring Inc. (BYSI)
BeyondSpring Q2 2022 Earnings Preview - Seeking Alpha
See More Headlines

BYSI Price History

BYSI Company Calendar

Last Earnings
12/29/2021
Today
6/06/2023
Next Earnings (Estimated)
7/18/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BYSI
Employees
91
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$1.25
High Stock Price Forecast
$1.25
Low Stock Price Forecast
$1.25
Forecasted Upside/Downside
0.0%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.35 million
Book Value
($0.36) per share

Miscellaneous

Free Float
27,515,000
Market Cap
$48.65 million
Optionable
Not Optionable
Beta
0.10

Key Executives

  • Lan Huang
    Chairman & Chief Executive Officer
  • G. Kenneth Lloyd
    Chief Scientific Officer













BYSI Stock - Frequently Asked Questions

What is BeyondSpring's stock price forecast for 2023?

0 analysts have issued 12-month target prices for BeyondSpring's stock. Their BYSI share price forecasts range from $1.25 to $1.25. On average, they expect the company's share price to reach $1.25 in the next year.
View analysts price targets for BYSI
or view top-rated stocks among Wall Street analysts.

How have BYSI shares performed in 2023?

BeyondSpring's stock was trading at $1.88 at the beginning of the year. Since then, BYSI shares have decreased by 33.5% and is now trading at $1.25.
View the best growth stocks for 2023 here
.

When is BeyondSpring's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, July 18th 2023.
View our BYSI earnings forecast
.

How were BeyondSpring's earnings last quarter?

BeyondSpring Inc. (NASDAQ:BYSI) released its quarterly earnings results on Wednesday, December, 29th. The company reported ($0.47) EPS for the quarter, topping analysts' consensus estimates of ($0.58) by $0.11. The firm had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.34 million.

What other stocks do shareholders of BeyondSpring own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BeyondSpring investors own include Exelixis (EXEL), Gilead Sciences (GILD), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Enterprise Products Partners (EPD), Johnson & Johnson (JNJ), Pfizer (PFE), Atara Biotherapeutics (ATRA), Dynavax Technologies (DVAX).

When did BeyondSpring IPO?

(BYSI) raised $4 million in an initial public offering (IPO) on Thursday, March 9th 2017. The company issued 200,000 shares at a price of $20.00 per share. Rodman & Renshaw (a Unit of H.C. Wainwright & Co.) served as the underwriter for the IPO.

What is BeyondSpring's stock symbol?

BeyondSpring trades on the NASDAQ under the ticker symbol "BYSI."

Who are BeyondSpring's major shareholders?

BeyondSpring's stock is owned by many different retail and institutional investors. Top institutional shareholders include Decheng Capital Management III Cayman LLC (12.74%), BlackRock Inc. (0.61%), Renaissance Technologies LLC (0.31%), Two Sigma Investments LP (0.13%), State Street Corp (0.10%) and Dimensional Fund Advisors LP (0.06%).

How do I buy shares of BeyondSpring?

Shares of BYSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BeyondSpring's stock price today?

One share of BYSI stock can currently be purchased for approximately $1.25.

How much money does BeyondSpring make?

BeyondSpring (NASDAQ:BYSI) has a market capitalization of $48.65 million and generates $1.35 million in revenue each year.

How can I contact BeyondSpring?

BeyondSpring's mailing address is 28 LIBERTY STREET 39TH FLOOR, NEW YORK NY, 10005. The official website for the company is www.beyondspringpharma.com. The company can be reached via phone at (646) 305-6387, via email at general@beyondspringpharma.com, or via fax at 1-646-882-4228.

This page (NASDAQ:BYSI) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -